This study is in progress, not accepting new patients
Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSF
- Dates
- study startedcompletion around
- Principal Investigator
- by Joel Palefsky, MD (ucsf)
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Joel Palefsky, MD (ucsf)
Joel Palefsky, M.D., C.M., F.R.C.P.(C). Professor of Medicine and Infectious Diseases at the University of California San Francisco School of Medicine. He is an internationally recognized expert on the molecular biology, treatment, pathogenesis and natural history of anogenital human papillomavirus infections, particularly in the setting of HIV infection.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Frantz Viral Therapeutics, LLC
- ID
- NCT05555862
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- About 17 people participating
- Last Updated